ML Marcovecchio, C Giannini, B Widmer, RN … - Diabetes Care, 2008 - Am Diabetes Assoc RESULTS—In subjects developing MA, a progressive rise in hs-CRP was detected with levels
significantly higher in the years after the onset of MA when compared with levels before MA onset
(P = 0.003; age-adjusted P = 0.06). After the onset of MA, hs-CRP levels were significantly ... Cited by 5 - Related articles - BL Direct - All 5 versions
[CITATION] Decline in renal function to end stage renal disease begins soon after the onset of …
BA Perkins, LH Ficociello, B Roshan, J Warram, A … - American Society of …, 2007 Cited by 3 - Related articles
MA Niewczas, LH Ficociello, AC Johnson, W … - Clinical Journal of the …, 2009 - Am Soc Nephrol Design, setting, participants, & measurements: The study group (the 2nd Joslin Kidney
Study) comprised patients with T1DM and normoalbuminuria (NA) (n = 363) or microalbuminuria
(MA) (n = 304). Impaired renal function (cC-GFR <90 ml/min) was present in only 10% of ... Cited by 3 - Related articles - All 3 versions
- ►nih.gov R Amin, B Widmer, AT Prevost, P Schwarze, J Cooper, … - British Medical Journal, 2008 - bmj.com You are seeing this message because your web browser does not support basic web
standards. Find out more about why this message is appearing and what you can do to make
your experience on this site better. ... Objectives To describe independent predictors for ... Cited by 13 - Related articles - BL Direct - All 8 versions
- ►asnjournals.org PP Wolkow, MA Niewczas, B Perkins, LH … - Journal of the American …, 2008 - Am Soc Nephrol Progressive renal function decline begins in one third of patients with microalbuminuria and
type 1 diabetes. This study examined whether this decline is associated with elevated excretion
of inflammatory markers in urine. Five inflammatory markers (IL-6, IL-8, monocyte ... Cited by 6 - Related articles - All 6 versions
MH Pillinger, P Rosenthal, AM Abeles - Bulletin of the NYU hospital for …, 2007 - ncbi.nlm.nih.gov Over the past decade, significant advances have been made regarding the pathogenesis, clinical
implications, and treatment of hyperuricemia. While physicians have understood for at least a
century that uric acid causes gout, we are now beginning to address the question of why ... Cited by 8 - Related articles - BL Direct
T Costacou, D Ellis, L Fried, TJ Orchard - American Journal of Kidney Diseases, 2007 - Elsevier BACKGROUND: The sensitivity of albuminuria in predicting loss of kidney function has been
questioned. We determined the sequence of kidney disease stages (microalbuminuria,
macroalbuminuria, low estimated glomerular filtration rate [eGFR], and end-stage renal ... Cited by 7 - Related articles - All 3 versions
DB Dunger, CP Schwarze, JD Cooper, B Widmer, … - Diabetic …, 2007 - pt.wkhealth.com Microalbuminuria (MA) remains the best predictive marker for future progression to
nephropathy, in subjects with Type 1 diabetes (T1D) [1–5], although, with improved glycaemic ... Correspondence to: Professor David B. Dunger, Department of Paediatrics, University ... Cited by 8 - Related articles - BL Direct - All 6 versions
BA Perkins, RG Nelson, AS Krolewski - The New England journal of …, 2005 - ncbi.nlm.nih.gov 1: N Engl J Med. 2005 Aug 25;353(8):842-4; author reply 842-4. Comment on: N
Engl J Med. 2005 May 19;352(20):2049-60. Cystatin C and the risk of death. Perkins
BA, Nelson RG, Krolewski AS. Publication Types: Comment; ... Cited by 8 - Related articles
